Literature DB >> 27276519

Design, Synthesis, and Biological Evaluation of Ganglioside Hp-s1 Analogues Varying at Glucosyl Moiety.

Jung-Tung Hung1, Chun-Hong Yeh2, Shih-An Yang2, Chiu-Ya Lin2, Hung-Ju Tai2, Ganesh B Shelke2, Daggula Mallikarjuna Reddy2, Alice L Yu1, Shun-Yuan Luo2.   

Abstract

Ganglioside Hp-s1 is isolated from the ovary of sea urchin Diadema setosum. It exhibited better neuritogenic activity than GM1 in pheochromocytoma 12 cells. To explore the roles of glucosyl moiety of Hp-s1 in contributing to the neurogenic activity, we developed feasible procedures for synthesis of Hp-s1 analogues (2a-2f). The glucosyl moiety of Hp-s1 was replaced with α-glucose, α-galactose, β-galactose, α-mannose, and β-mannose, and their biological activities on SH-SY5Y cells and natural killer T (NKT) cells were evaluated. We found that the orientation of C-2 hydroxyl group at glucosyl moiety of Hp-s1 plays an important role to induce neurite outgrowth of SH-SY5Y cells. Surprisingly, compound 2d could activate NKT cells to produce interleukin 2, although it did not show great activity on neurite outgrowth of SH-SY5Y cells. In general, the Hp-s1 might be considered as a lead compound for the development of novel drugs aimed at modulating the activity of neuronal cells.

Entities:  

Keywords:  Ganglioside Hp-s1; SH-SY5Y cells; glucosyl moiety of Hp-s1; neurogenic activity

Mesh:

Substances:

Year:  2016        PMID: 27276519     DOI: 10.1021/acschemneuro.6b00069

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  2 in total

Review 1.  Chemistry and Biology of Bioactive Glycolipids of Marine Origin.

Authors:  Iván Cheng-Sánchez; Francisco Sarabia
Journal:  Mar Drugs       Date:  2018-08-22       Impact factor: 5.118

2.  Halogen-directed chemical sialylation: pseudo-stereodivergent access to marine ganglioside epitopes.

Authors:  Taiki Hayashi; Alexander Axer; Gerald Kehr; Klaus Bergander; Ryan Gilmour
Journal:  Chem Sci       Date:  2020-03-26       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.